|
Dr. Sachs is globally recognized for his outstanding medical research achievements in the area of transplantation and specifically Xenotransplantation.
Dr. Sachs was directly involved and responsible for the development of a number of the research and scientific advances which now form the basis for the Xeno exclusive license with MGH.
As an independent Director of Xeno, Dr. Sachs’ presence will greatly assist the company in reaching its development goals.
Biography
Dr. David H. Sachs has worked at the interface between basic research and clinical applications in transplantation for more than 30 years and currently serves as Professor of Surgery and Immunology at the Harvard Medical School and Director of the Transplantation Biology Research Center at the Massachusetts General Hospital.
Dr. Sachs has published over 650 articles in scientific journals. His research achievements include: 1) discovery of Ia (Class II) antigens in 1973; 2) development of monoclonal anti-bodies to MHC antigens; 3) development of a unique large animal model for transplantation using miniature swine; 4) use of mixed marrow reconstitution as a means of inducing specific transplantation tolerance; and 5) studies of specific transplantation tolerance to allografts and xenografts in murine, swine and primate models. Dr. Sachs is a member of the Editorial Board of several journals in his field, including: The Journal of Experimental Medicine, Immunological Reviews, Bone Marrow Transplantation and Clinical Transplantation, and is Editor of Transplantation and founding Editor of Xeno Transplantation.
Dr. Sachs was the recipient of the Public Health Service Commendation Medal in 1979 and of the Meritorious Service Award in 1984. He was a Councilor of the Transplantation Society from 1988-1994 and Vice-President from 1996-1998. From 1992-1996, Dr. Sachs was a member of the Immunobiology Study Section at the National Institutes of Health, and has served on the Immunology Executive Committee at Harvard Medical School since 1991. Dr. Sachs was elected to the Institute of Medicine of the National Academy of Sciences in 1996. He served as Chairman of the Scientific Advisory Board of BioTransplant and Immerge BioTherapeutics, Inc. and serves on the Scientific Advisory Board of the Lombard Odier Immunology Fund. In 1998 Dr. Sachs received the Jean Borel Award in Transplantation and the ASTP/Novartis Established Investigator Award.
In 2001 Dr. Sachs was presented the Award for Distinguished Contributions to Health Research by The Medical Foundation and the Mary Jane Kugel Award by the Juvenile Diabetes Research Foundation. In 2005, he received the Roche Ernest Hodge Memorial Award (formerly called the Roche American Society of Transplantation Distinguished Achievement Award), the highest award bestowed by the American Society of Transplantation.
| 